All News

Lung cancer screening rates in the United States remained low and unchanged in 2015 despite recommendations that high-risk current and former smokers be screened.

Buy in from physicians and lack of enthusiasm from payers are seen as barriers to moving quickly into value-based models.

Feedback received by the Institute of Clinical Effectiveness Research during this time will be evaluated and incorporated as seen fit, before the final changes are made to the framework.

Early discharge from the emergency department resulted in more than 10,000 Medicare patients dying, annually. Researchers determined that low-volume hospitals actually had higher rates of early death.

Amgen's Repatha was shown to reduce the risk of cardiovascular events, such as cardiovascular death and myocardial infarction, in phase 3 of the FOURIER study. Full results will be presented in March 2017 at the American College of Cardiology 66th Scientific Sessions.

A recent literature review confirmed that adult offspring of people with chronic obstructive pulmonary disease are at higher risk of being diagnosed with the disease themselves.

A recent study in BMJ Open Diabetes Research & Care indicates that the prevalence of diabetes is higher among individuals infected with HIV than in the general population.

The National Health Policy Conference hosted by AcademyHealth, January 30-31, 2017, in Washington DC, delivered on its promise of insightful discussions on the current and future trends within healthcare.

This week, the top managed care stories included Republicans pushing HHS secretary nominee Tom Price, R-Georgia, through without Democrats, PhRMA meeting with President Donald Trump, and patients complaining of price fixing in an insulin lawsuit.

Coverage of our peer-reviewed research in the healthcare and mainstream press.

Reports explain that plans for Medicaid block grants or per capita caps overlook who really uses Medicaid. It's mostly children.

Significant reductions in A1C were found at both doses, and bigger declines were seen among patients with the worst glycemic control. The cardiovascular outcomes trial for the SGLT2 inhibitor took a different turn after a rival drug showed a CV benefit.

The University of Michigan Center for Value-Based Insurance Design (V-BID) celebrated significant initiative milestones in 2016.

A review of 15 disease-modifying therapies (DMTs) for the treatment of relapsing-remitting and primary-progressive multiple sclerosis (MS) has found that prices for most of these drugs are not well-aligned with added value for patients.

A white paper commissioned by the Community Oncology Alliance (COA) delved into the practice of “direct and indirect remuneration” fees administered by pharmacy benefit managers and how they could drive up drug prices for Medicare Part D beneficiaries and taxpayers.

A study last year found that more than half of all California adults have diabetes or prediabetes.

At the AcademyHealth National Health Policy Conference in Washington DC, Senator Bill Cassidy spoke about the potential replacement of the Affordable Care Act and the options that the Republican administration is considering for the replacement.

Teledermatology is advertised a major breakthrough in telehealth. But, is the tort system ready for widespread adoption?

On Tuesday, President Donald Trump announced that he would nominate federal judge Neil Gorsuch to fill the vacant Supreme Court seat, which could have important implications for healthcare-related cases.

The change is part of a far-reaching public health law passed a year ago. The French have curbed candy machines and even french fries.

During a plenary session at the AcademyHealth National Health Policy Conference, Senator Tim Kaine, D-Virginia, discussed the Affordable Care Act and efforts to replace it or at least change it.

Pembrolizumab (Keytruda) has received green light from the European Commission for the first-line treatment of a select population of adult patients with metastatic non-small cell lung cancer.

Republicans on the Senate Finance Committee suspended rules to clear Cabinet nominees Price and Mnuchin after Democrats boycotted the vote the previous day.

During the National Cancer Prevention Month, there will be renewed fervor among healthcare providers to ensure individuals pay greater attention toward preventive measures against cancer.

With considerable evidence that interventions aimed at social determinants of health can positively influence health outcomes and costs, the discourse is changing among providers and policy influencers to look beyond disease and clinical conditions.